The prevalence of this BARD1 variant was significantly higher in Icelandic BC cases who also carried the pathogenic BRCA2 c.771_775del; p.Asn257LysfsTer17 variant known to be a founder pathogenic variant in this population [15]. The gene discussed is BRCA2; the disease is breast cancer.